David S. Grayzel, Director at Surface Oncology, Inc. (SURF), bought 3,281,817 shares at $15.00 ($1.5M) on 2018-04-23, disclosed to the SEC on 2018-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,181,817 | $0 | 0.0% |
| 2 | $15.00 | 100,000 | $1.5M | 100.0% |
| Total | $0.46 avg | 3,281,817 | $1.5M | 100% |
| Filing → |
| SURF | SELL | 2020-12-21 | $30.8M | — | Filing → |
| SURF | SELL | 2020-12-21 | $13.8M | — | Filing → |